CIP
Chartwell Investment Partners Portfolio holdings
AUM
$2.91B
1-Year Return
40.48%
This Quarter Return
+11.78%
1 Year Return
+40.48%
3 Year Return
+57.19%
5 Year Return
+149.04%
10 Year Return
+395.35%
AUM
$2.89B
AUM Growth
+$38.7M
(+1.4%)
Cap. Flow
-$217M
Cap. Flow
% of AUM
-7.51%
Top 10 Holdings %
Top 10 Hldgs %
18.43%
Holding
453
New
33
Increased
146
Reduced
208
Closed
44
Top Buys
| 1 |
Gates Industrial
GTES
|
$11.7M |
| 2 |
Cushman & Wakefield
CWK
|
$11.7M |
| 3 |
Marvell Technology
MRVL
|
$9.93M |
| 4 |
UnitedHealth
UNH
|
$8.2M |
| 5 |
Sherwin-Williams
SHW
|
$7.28M |
Top Sells
| 1 |
Eagle Materials
EXP
|
$13.6M |
| 2 |
nVent Electric
NVT
|
$12.9M |
| 3 |
Integer Holdings
ITGR
|
$11.9M |
| 4 |
Healthcare Realty
HR
|
$11.2M |
| 5 |
NextEra Energy, Inc.
NEE
|
$10.8M |
Sector Composition
| 1 | Technology | 23.57% |
| 2 | Financials | 14.29% |
| 3 | Healthcare | 12.06% |
| 4 | Industrials | 11.03% |
| 5 | Consumer Discretionary | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
IDEAYA Biosciences
IDYA
$2.26B
| $756K | 0.03% |
+17,241
| New | +$756K |
|
377
Liquidia Corp
LQDA
$2.48B
| $750K | 0.03% |
50,833
-43,791
| -46% | -$646K |
|
378
Churchill Downs
CHDN
$7.15B
| $743K | 0.03% |
6,003
+142
| +2% | +$17.6K |
|
379
ANI Pharmaceuticals
ANIP
$2.08B
| $742K | 0.03% |
10,726
+254
| +2% | +$17.6K |
|
380
AeroVironment
AVAV
$11.3B
| $739K | 0.03% |
4,818
+114
| +2% | +$17.5K |
|
381
iShares Core S&P 500 ETF
IVV
$666B
| $676K | 0.02% |
1,286
| – | – |
|
382
Immunovant
IMVT
$2.81B
| $674K | 0.02% |
20,865
+495
| +2% | +$16K |
|
383
Healthpeak Properties
DOC
$12.5B
| $653K | 0.02% |
34,807
-4,363
| -11% | -$81.9K |
|
384
Federal Realty Investment Trust
FRT
$8.71B
| $651K | 0.02% |
6,379
-6,485
| -50% | -$662K |
|
385
Huron Consulting
HURN
$2.51B
| $643K | 0.02% |
6,655
-6,800
| -51% | -$657K |
|
386
Fabrinet
FN
$12.9B
| $576K | 0.02% |
3,047
-2,205
| -42% | -$417K |
|
387
Weatherford International
WFRD
$4.5B
| $571K | 0.02% |
4,950
+120
| +2% | +$13.8K |
|
388
Axsome Therapeutics
AXSM
$6.21B
| $536K | 0.02% |
+6,706
| New | +$536K |
|
389
Ionis Pharmaceuticals
IONS
$9.46B
| $510K | 0.02% |
11,756
-1,226
| -9% | -$53.2K |
|
390
Magnite
MGNI
$3.54B
| $490K | 0.02% |
+45,583
| New | +$490K |
|
|
CTLT
391
DELISTED
CATALENT, INC.
CTLT
| $482K | 0.02% |
8,530
+200
| +2% | +$11.3K |
|
392
QuidelOrtho
QDEL
$1.89B
| $439K | 0.02% |
+9,157
| New | +$439K |
|
393
Cabot Corp
CBT
$4.31B
| $426K | 0.01% |
4,625
+108
| +2% | +$9.95K |
|
394
Wolfspeed
WOLF
$194M
| $382K | 0.01% |
12,959
+310
| +2% | +$9.14K |
|
395
Synaptics
SYNA
$2.69B
| $356K | 0.01% |
3,647
+86
| +2% | +$8.4K |
|
396
Evolus
EOLS
$486M
| $337K | 0.01% |
+24,093
| New | +$337K |
|
397
Cytokinetics
CYTK
$5.95B
| $281K | 0.01% |
4,013
-22,440
| -85% | -$1.57M |
|
398
Spyre Therapeutics
SYRE
$1.03B
| $259K | 0.01% |
+6,835
| New | +$259K |
|
399
Darling Ingredients
DAR
$4.99B
| $234K | 0.01% |
5,023
-4,738
| -49% | -$221K |
|
400
iShares Russell 2000 ETF
IWM
$67.4B
| $202K | 0.01% |
+961
| New | +$202K |
|